FDA approves new antibiotic to treat community-acquired bacterial pneumonia

The FDA approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.

Source: FDA Center for Drug Evaluation and Research - What's New - August 19, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news